Skip to content

CareCloud, Inc. CCLD Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Phreesia logo
PhreesiaPHR
LifeMD, Inc. logo
LifeMD, Inc.LFMD

Other financials

Income statement

See full
Revenue$31.3M+13.2%
Operating income$1.0M-50.5%
Net income$922.0K-52.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$3.4M-50.7%
Total debt$5.0M+58.5%
Total equity$58.3M+7.7%
Total assets$86.7M+17.9%

Cash flow

See full
Operating cash flow$3.6M-29.4%
CapEx$412.0K-34.0%
Free cash flow$3.2M-28.7%

Valuation

See full
Market cap$90.09M-2.2%
Enterprise value$91.73M+7.6%
P/E9.2×+1.0×
P/S0.7×-0.1×

Profitability

See full
Operating margin8.3%-1.5pp
Net margin7.9%-1.1pp
FCF margin18.1%+0.6pp

Returns & leverage

See full
Return on equity17.4%-3.6pp
Debt / equity0.1×0.0×
Current ratio1.1×-0.6×

Where this comes from

Reported directly by CareCloud, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: CareCloud, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareCloud, Inc.'s cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareCloud, Inc.'s cash and cash equivalents, end of period?
CareCloud, Inc. (CCLD) reported cash and cash equivalents, end of period of $3.85M in Q1 2026.
How has CareCloud, Inc.'s cash and cash equivalents, end of period changed year-over-year?
CareCloud, Inc.'s cash and cash equivalents, end of period decreased by 43.4% year-over-year, from $6.81M to $3.85M.
What is the long-term trend for CareCloud, Inc.'s cash and cash equivalents, end of period?
Over 5 years (2020 to 2025), CareCloud, Inc.'s cash and cash equivalents, end of period has grown at a -29.6% compound annual growth rate (CAGR), from $20.93M to $3.62M.